Ulf Klein
About Ulf Klein
Ulf Klein is the Director Program Management at Novocure in Lucerne, Switzerland, with extensive experience in program management and strategic operations in the medical field.
Title
Ulf Klein currently holds the position of Director Program Management at Novocure in Lucerne, Switzerland.
Current Role at Novocure
Ulf Klein is the Director Program Management at Novocure, based in Lucerne, Switzerland. In this role, he leads a team of project managers and delivers a comprehensive PMO service catalogue. He spearheads the integration of global medical affairs strategy with corporate objectives, ensuring cohesive planning for product launches. Ulf is part of the Strategic Operations leadership team, contributing to high-level decision-making and strategic planning.
Previous Positions
Before joining Novocure, Ulf Klein worked at T-knife Therapeutics as Program Director for 11 months in Berlin, Germany in 2022. Prior to that, he was a Senior Global Program Manager at Novartis Oncology from 2019 to 2021 in Basel, Switzerland. He also served as Transformation Manager in Regulatory Affairs at Roche from 2017 to 2019, and as Senior Consultant at Altran Switzerland from 2016 to 2017 in Zürich, Switzerland.
Experience at Novartis
Ulf Klein had multiple roles at Novartis. He served as Head of Portfolio Support and Automation in 2015-2016, Senior Laboratory Head / Project Manager in early Development from 2013 to 2015, Laboratory Head from 2010 to 2013, and Project Leader (Post-Doc) from 2009 to 2010. Many of these roles were based in the Basel Area, Switzerland.
Education and Expertise
Ulf Klein has a strong academic background in the fields of oncology and molecular biology. He achieved his Doctor of Philosophy (PhD) at Max-Planck Institute for Biochemistry, studying Oncology and Cancer Biology from 2004 to 2009. He also holds a Master of Science (MS) in Molecular Biology from the International Max-Planck Research School, completed from 2002 to 2004. Additionally, he studied at The Institute of Cancer Research in London and at the Max-Planck Institute for Biochemistry, focusing on Structural Biology. His undergraduate studies in general biology were completed at the University of Hannover, where he achieved a pre-diploma.